LD proved to be a potent P-gp inhibitor with EC<sub>50</sub> ∼ 1 μM, capable of considerable sensitization of P-gp-expressing cancer cells to conventional cytostatic drugs in vitro. The gene discussed is PGP; the disease is cancer.